Health Care · Pharmaceutical Preparations · OTC · CIK 1563577 · FYE Dec 31 · Prices AT CLOSE 2026-07-20 (USD) · STALE: the feed has not advanced this name
Last $16.28 · Day +0.00% · Mkt cap $2.6B · P/E (FY) 25.4× · 1Y +219.2% · Off 52W high −45.7% · Vol (1Y) 142.1%
Price 2023-07-20 → 2026-07-20
$562 $376 $190 $3 2023-07-20 2024-07-19 2025-07-17 2026-07-20 $562 $376 $190 $3 2023-07-20 2025-01-21 2026-07-20 GRTX close: $562 on 2023-07-20 to $16 on 2026-07-20.
Split-adj closes · 240 of 1,680 · price returnⓘ
At a glance
Short interest 0.0% of sh out Days to cover 1.0d Top-10 13F concentration 100.0% Next report (est.) 2026-11-14
SI 2026-06-30 · 13F 2026-Q1ⓘ
Key fundamentals FY 2025
P/E (FY) 25.4× Earnings (TTM) $149.0M
FY ratios · TTM sales/earnings (USD)ⓘ
Trailing returns
YTD +270.0% 1Y +219.2% 3Y −97.1% 5Y −99.2% Since incept. (ann.) −52.5%
Total return · from 2019-11-07ⓘ
Risk
Ann. volatility (1Y) 142.1% Ann. volatility (3Y) 145.2% Sharpe (1Y) 1.41 Sharpe (3Y) 0.00 Max drawdown (1Y) −38.5% Max drawdown (3Y) −99.4% Beta (3Y vs SPY) 3.79
Daily returns, ann.ⓘ
Top institutional holders 13F 2026-Q1
Manager Shares Value % sh out QoQ Ascentis Independent Advisors 93 $4 0.00% new
Δ vs 2025-Q4ⓘ
Latest reported quarters last report 2026-05-14
Period end Reported EPS EPS YoY Revenue Rev YoY 2026-03-31 2026-05-14 — — — — 2025-09-30 2025-11-13 — — — — 2025-06-30 2025-08-13 $0.00 — — — 2025-03-31 2025-05-15 — — — —
As-reported XBRL · next 2026-11-14 est.ⓘ
Basis & disclosures
EOD closes · nothing imputed or averaged · absent “—”As-of differs by block · 13F = US long, 45+d lag, LOWER boundNot investment advice · no recommendation, price target or solicitationEDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology 
